TTRX – turn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Turn Therapeutics Secures $25M Financing for Dermatology Trials [Los Angeles Times (CA)]
Turn Therapeutics (TTRX) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $8.00 price target on the stock.
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group
Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs
Form SCHEDULE 13G Turn Therapeutics Inc. Filed by: Burnam Bradley Evan
Form 4 Turn Therapeutics Inc. For: Apr 02 Filed by: BEB Holdings, LLC
Form 4 Turn Therapeutics Inc. For: Apr 02 Filed by: GOLDEN ARTHUR F
Form 4 Turn Therapeutics Inc. For: Apr 01 Filed by: Chaudhary Zuraiz
Form 4 Turn Therapeutics Inc. For: Apr 01 Filed by: BEB Holdings, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.